GSK3B and schizophrenia: In contrast, aripiprazole showed much stronger effects on the levels of p-GSK3β in several brain regions (e.g. PFC, NAc), probably elucidating haloperidol’s inability to treat negative symptoms of schizophrenia, since acute treatment with some other second-generation antipsychotics were able to widely affect GSK3β [68].